<DOC>
	<DOCNO>NCT01103271</DOCNO>
	<brief_summary>Placebo pill ( pill active ingredient ) show research study somehow produce self-healing process . The purpose study determine whether people willing enter open-label non-deceptive placebo treatment Major Depressive Disorder ( MDD ) whether open-label placebo effective treat MDD context supportive physician-patient relationship .</brief_summary>
	<brief_title>Pilot Study Open-label Placebo Treat Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Men woman age 1860 year old . Current Major Depressive Disorder ( MDD ) Pregnant woman woman child bear potential use medically accept mean contraception . Patients serious suicide homicide risk . Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease . The following Diagnostic Statistical Manual Mental DisordersIV diagnose : 1 ) organic mental disorder ; 2 ) substance use disorder , include alcohol , active within last year ; 3 ) schizophrenia ; 4 ) delusional disorder ; 5 ) psychotic disorder elsewhere classify ; 6 ) bipolar disorder ; 7 ) acute bereavement ; 9 ) severe borderline antisocial personality disorder ; 10 ) current primary diagnosis panic disorder , social phobia , generalize anxiety disorder ( GAD ) , obsessive compulsive disorder ( OCD ) ( disorder present chief complaint and/or onset precede onset major depressive disorder ) . Uncontrolled seizure disorder . Patients mood congruent mood incongruent psychotic feature . Current use psychotropic drug . Exception : Patients stable dose 30 day class medication nonbenzodiazepine sedative , anxiolytic benzodiazepine , nonnarcotic analgesic may include . Flexibility allow base physician discretion . Clinical laboratory evidence hypothyroidism . Patients take investigational psychotropic drug within last year . Patients respond two antidepressant trial adequate dos ( e.g. , fluoxetine 40 mg/day high ) duration ( e.g. , six week ) past five year . Any concomitant form psychotherapy ( depression focus )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>depression</keyword>
	<keyword>placebo effect</keyword>
	<keyword>complementary therapy</keyword>
	<keyword>alternative therapy</keyword>
</DOC>